Table 1.
Demographics of study participants
| CATEGORY | COUNT (% of sample) |
| Age (at enrollment): | |
| 45–49 | 2 (8.7%) |
| 50–59 | 1 (4.4%) |
| 60–69 | 7 (30.4%) |
| 70–79 | 10 (43.5%) |
| 80–89 | 3 (13.0%) |
| Gender: | |
| Female | 17 (73.9%) |
| Male | 6 (26.1%) |
| Ethnicity: | |
| Black, not of Hispanic origin | 3 (13.0%) |
| White, not of Hispanic origin | 18 (78.3%) |
| Hispanic | 1 (4.4%) |
| Other, Filipino | 1 (4.4%) |
| Education Level: | |
| High school/GED | 2 (8.7%) |
| Associate degree/some college | 2 (8.7%) |
| Bachelor’s degree | 7 (30.4%) |
| Master’s or Doctorate degree | 10 (43.5%) |
| Other | 2 (8.7%) |
| APOE Alleles: | |
| 2/3 | 3 (13.0%) |
| 3/3 | 8 (34.7%) |
| 3/4 | 9 (39.1%) |
| 4/4 | 3 (13.0%) |
| Family history of Alzheimer’s Disease: | |
| Yes | 11 (47.8%) |
| No | 11 (47.8%) |
| Unknown | 1 (4.4%) |
| Family history of another kind of dementia: | |
| Yes | 7 (30.4%) |
| No | 16 (69.6%) |
| Diabetes: | |
| Yes | 5 (21.7%) |
| No | 18 (78.3%) |
| Hypertension: | |
| Yes | 10 (43.5%) |
| No | 13 (56.5%) |
| Taking donepezil or memantine: | |
| Yes | 3 (13.1%) |
| No | 20 (86.9%) |